PRESCIENT THERAPEUTICS LIMITED — Director's Dealing 2008

Mar 19, 2008

Notice of Change of Director’s Interest (Appendix 3Y Notice) Notice No. 01

Name of entity:	Virax Holdings Limited
ABN No:	56 006 569 106

We, Virax Holdings Limited, give ASX the following information under listing rule 3.19A.1 and as agent for the Director for the purposes of section 205G of the Corporation Act.

Name of Director	Albert Ting
Date of last notice		Last Notice No.

Part 1 – Change of Director’s relevant interest in securities*

Direct or indirect interest	Indirect	Indirect	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevantinterest	Albert & Teresa Ting Pty Ltd Havagoal Pty Ltd
Date of change	29 February 2008
Class	Fully Paid Ordinary Share	Options	Convertible Notes
No. of securities held prior to change	2,670,025	259,834	0
Number acquired			137,800
Number disposed
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation			$13,780
No. of securities held after change	VHL 2,670,025	VHLOB 259,834	VHLG 137,800
Nature of change Example: on-market trade, off- market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	The Notes were applied for under a Shortfall Placement Agreement as referred to in the Prospectus dated 19 December 2007. The Notes were registered as part of the Appendix 3B notification on 29 February 2008.

Notice of Change of Director’s Interest (Appendix 3Y Notice) Notice No. 01

Direct or indirect interest	Direct	Direct	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevantinterest
Date of change	5 March 2008
Class	Fully Paid Ordinary Shares	Options	Convertible Notes
No. of securities held prior to change	3,829,283	207,826
Number acquired
Number disposed		50,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		$500.00
No. of securities held after change	VHL 3,829,283	VHLOB 157,826
Nature of change Example: on-market trade, off- market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On market sale of options.

Notice of Change of Director’s Interest (Appendix 3Y Notice) Notice No. 01

Part 2 – Change of Director’s interests in contracts*

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change: Note: Details are only required for a contract in relation to which the interest has changed. Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Interest after change

*** If insufficient space please provide attachment and insert attachment number in appropriate space.**

Signed

20 March 2008 _____ ____ John Morrison Date

John Morrison Company Secretary Virax Holdings Limited